Davide Leone & Partners Investment Co Ltd's Q3 2019 13F: 3 new positions, 6 exits
Form 13F-HR for the quarter ended Sep 30, 2019 · filed Nov 14, 2019 · 10 reported positions · accession 0001172661-19-002239
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | ANADARKO PETE CORP (APC) | 12.1% | — | −12.1 pts | −1.6M sh | −100% |
| Exited | ARRAY BIOPHARMA INC (ARRY) | 9.1% | — | −9.1 pts | −1.82M sh | −100% |
| Reduced | ZAYO GROUP HLDGS INC (ZAYO) | 9.1% | 9.1% | +0.1 pts | −1.2M sh | −47% |
| New | SPRINT CORPORATION (S) | — | 7.6% | +7.6 pts | +6.27M sh | new |
| New | BIOGEN INC (BIIB) | — | 6.4% | +6.4 pts | +139K sh | new |
| Reduced | INCYTE CORP (INCY) | 6.7% | 5.5% | −1.2 pts | −357K sh | −49% |
| Increased | ALTABA INC (AABA) | 31.4% | 21.0% | −10.4 pts | +1.24M sh | +29% |
| Exited | NIELSEN HLDGS PLC (NLSN) | 2.9% | — | −2.9 pts | −1.2M sh | −100% |
| New | VERTEX PHARMACEUTICALS INC (VRTX) | — | 2.6% | +2.6 pts | +76,558 sh | new |
| Exited | LIONS GATE ENTMNT CORP (LGFA) | 1.5% | — | −1.5 pts | −1.11M sh | −100% |
| Reduced | AT&T INC (T) | 8.3% | 16.9% | +8.6 pts | −38,776 sh | −2% |
| Exited | LIONS GATE ENTMNT CORP (LGFB) | 0.2% | — | −0.2 pts | −156K sh | −100% |
| Exited | RED HAT INC (RHT) | 0.1% | — | −0.1 pts | −6,601 sh | −100% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
Changes in the top 10 this quarter: S entered · BIIB entered · VRTX entered · BRK-A entered · APC left · ARRY left · NLSN left · LGFA left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ALTABA INC (AABA) | 31.4% | 21.0% | |
| 2 | CELGENE CORP (CELG) | 10.0% | 19.8% | |
| 3 | AT&T INC (T) | 8.3% | 16.9% | |
| 4 | BLACKBERRY LTD (BB) | 8.6% | 11.1% | |
| 5 | ZAYO GROUP HLDGS INC (ZAYO) | 9.1% | 9.1% | |
| 6 | SPRINT CORPORATION (S) | 0.0% | 7.6% | Entered the top 10 |
| 7 | BIOGEN INC (BIIB) | 0.0% | 6.4% | Entered the top 10 |
| 8 | INCYTE CORP (INCY) | 6.7% | 5.5% | |
| 9 | VERTEX PHARMACEUTICALS INC (VRTX) | 0.0% | 2.6% | Entered the top 10 |
| 10 | BERKSHIRE HATHAWAY INC DEL (BRK-A) | 0.0% | 0.1% | Entered the top 10 |
| — | ANADARKO PETE CORP (APC) | 12.1% | 0.0% | Left the top 10 |
| — | ARRAY BIOPHARMA INC (ARRY) | 9.1% | 0.0% | Left the top 10 |
| — | NIELSEN HLDGS PLC (NLSN) | 2.9% | 0.0% | Left the top 10 |
| — | LIONS GATE ENTMNT CORP (LGFA) | 1.5% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | ALIBABA GROUP HLDG LTD (BABA) | Put | 1.47M | 0 | $0 |